Office of Sponsored Programs
News and Updates
NEW requirement in place that current and pending support information and biographical sketches will need to be created in SciENcv for each individual designated as Senior Personnel. Please note that use of SciENcv requires the Senior Personnel to have an ORCID iD.
Additional Information:
NSF FUNDING OPPORTUNITES WEBSITE:
https://beta.nsf.gov/funding/opportunities
NEW NSF PAPPG 2023:
https://beta.nsf.gov/policies/pappg/23-1
NSF HELP FROM OSP:
The new OSP NSF 2023 Checklist is now ready. Please contact us with any questions. Please let us know of any upcoming proposals, so we can help you achieve the best possible submission.
NIH Guide for Grants and Contracts
March 22, 2024
Weekly NIH Funding Opportunities and Notices
General Notices
- Notice of Pre-Application Technical Assistance Webinar for RFA-DA-25-060
(NOT-DA-24-019)
National Institute on Drug Abuse
- Notice of NIBIB Participation in NOT-EY-23-009 "Notice of Special Interest (NOSI):
Quantum Sensing in Biomedical Applications (SBIR/STTR)"
(NOT-EB-24-005)
National Institute of Biomedical Imaging and Bioengineering
- Notice of Informational Webinar for the National Institute of General Medical Sciences
Medical Scientist Training Program (MSTP) (T32)
(NOT-GM-24-029)
National Institute of General Medical Sciences
- Notice of Information: NICHD to issue a Research Opportunity Announcement to support
Advancing Cures and Therapies and ending ENDOmetriosis diagnostic delays - ACT ENDO
(OTA Clinical Trial Optional)
(NOT-HD-24-016)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
- NHLBI Announces New Policies Regarding Budget Guidelines for SBIR/STTR Applications
(NOT-HL-24-008)
National Heart, Lung, and Blood Institute
- Notice of Informational Webinar for PAR-23-144, STrengthening Research Opportunities
for NIH Grants (STRONG): Structured Institutional Needs Assessment and Action Plan
Development for Resource Limited Institutions (RLIs) (UC2 - Clinical Trial Not Allowed)
(NOT-MD-24-011)
National Institute on Minority Health and Health Disparities
National Center for Advancing Translational Sciences
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
- Guidance on Flexibilities for Conducting Semiannual Inspections of Animal Facilities
(NOT-OD-24-075)
Office of the Director, NIH
- Guidance on Flexibilities for Conducting Semiannual Program Review
(NOT-OD-24-076)
Office of the Director, NIH
- Notice to Rescind NOT-OD-21-080 "Updated Notice of Limited Availability of Research
Non-Human Primates"
(NOT-OD-24-080)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
- Registration Open for Webinar on NIH Simplified Review Framework for NIH Research
Project Grants (RPGs): Implementation and Impact on Funding Opportunities
(NOT-OD-24-081)
Office of the Director, NIH
- Notice Announcing Publication of Development and Application of Ophthalmic Imaging
Technologies to Advance Our Understanding of Systemic Diseases (OT2) Research Opportunity
Announcement
(NOT-RM-24-007)
Office of Strategic Coordination (Common Fund)
- Notice Announcing the Systems Biology Data Platform Leveraging the Accelerating Medicines
Partnership (OT2)
(NOT-RM-24-008)
Office of Strategic Coordination (Common Fund)
- Request for Information (RFI): Inviting Comments and Feedback on the National Institute
of Diabetes and Digestive and Kidney Disease, Division of Kidney, Urologic, and Hematologic
Diseases Institutional Network Award (U2C-TL1)
(NOT-DK-24-018)
National Institute of Diabetes and Digestive and Kidney Diseases
Notice of Changes to Funding Opportunities
- Notice of Change to Budget Information Listed in PAR-21-357, "Research Enhancement
Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical
Trial Required)"
(NOT-AG-23-085)
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
National Library of Medicine
- Notice of Early Expiration of "Notice of Special Interest (NOSI): Investigations on
Inborn Errors of Immunity/Primary Immunodeficiencies", NOT-AI-21-032
(NOT-AI-24-026)
National Institute of Allergy and Infectious Diseases
- Notice of Early Expiration of "Notice of Special Interest (NOSI): Molecular and Genetic
Characterization of Inborn Errors of Immunity", NOT-AI-21-082
(NOT-AI-24-027)
National Institute of Allergy and Infectious Diseases
- Notice of Change to RFA-CA-22-045, NCI Outstanding Investigator Award (R35 Clinical
Trial Optional)
(NOT-CA-24-038)
National Cancer Institute
- Notice of Change to Extend Application Due Dates for PAR-21-305 - Time-Sensitive Obesity
Policy and Program Evaluation (R01 Clinical Trial Not Allowed)
(NOT-DK-24-014)
National Institute of Diabetes and Digestive and Kidney Diseases
National Cancer Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Office of Disease Prevention
- Notice of Change to Funding Opportunity: RFA-FD-24-030 Drug Development Tools Research
Grants (U01) Clinical Trials Optional
(NOT-FD-24-006)
Food and Drug Administration
- Notice of Change to Funding Opportunity: RFA-FD-24-035 Development and Maintenance
of the Animal Food Regulatory Program Standards (U19) Clinical Trial Not Allowed
(NOT-FD-24-007)
Food and Drug Administration
- Notice of Change to Funding Opportunity: RFA-FD-24-035 Development and Maintenance
of the Animal Food Regulatory Program Standards (U19) Clinical Trial Not Allowed
(NOT-FD-24-008)
Food and Drug Administration
- Notice of Correction to Key Dates Listed in Ruth L. Kirschstein National Research
Service Award (NRSA) Individual Fellowships
(NOT-OD-24-082)
Office of the Director, NIH
- Notice of Change to the Instructions for Appendices in PAR-24-105 "Limited Competition:
Mutant Mouse Resource and Research Centers (U42 Clinical Trial Not Allowed)"
(NOT-OD-24-083)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
- Termination of NOSI NOT-OD-22-192 - Administrative Supplements to NCATS CTSA Program
KL2/K12 Institutional Career Development Awards as part of the INCLUDE (Investigation
of Co-occurring Conditions across the Lifespan to Understand Down syndrome) Project
(NOT-TR-24-014)
National Center for Advancing Translational Sciences
Notices of Intent to Publish
- Notice of Intent to Publish a Funding Opportunity Announcement for Specialized Alcohol
Research Centers (P50 Clinical trial Optional)
(NOT-AA-24-007)
National Institute on Alcohol Abuse and Alcoholism
- Notice of Intent to Publish a Funding Opportunity Announcement for Comprehensive Alcohol
Research Centers (P60 Clinical trial Optional)
(NOT-AA-24-008)
National Institute on Alcohol Abuse and Alcoholism
- Notice of Intent to Publish a Funding Opportunity Announcement for REsearch Across
Complementary and Integrative Health Institutions (REACH) Virtual Resource Centers
(U24 Clinical Trial Not Allowed)
(NOT-AT-24-037)
National Center for Complementary and Integrative Health
- Notice of Intent to Publish a Funding Opportunity Announcement for Cystic Fibrosis
Research and Translation Centers (P30 Clinical Trial Optional)
(NOT-DK-24-017)
National Institute of Diabetes and Digestive and Kidney Diseases
- Notice of Intent to Publish a Funding Opportunity Announcement for Understanding the
Intersection of Social Inequities to Optimize Health and Reduce Health Disparities:
The Axes Initiative (R01 Clinical Trial Optional)
(NOT-NR-24-009)
National Institute of Nursing Research
National Institute of Mental Health
Office of Research on Women's Health
Notices of Special Interest
- Notice of Special Interest (NOSI): Inborn Errors of Immunity/Primary Immunodeficiencies
(NOT-AI-24-024)
National Institute of Allergy and Infectious Diseases
- Notice of Special Interest (NOSI): Development of Imaging Techniques for High Resolution
and Functional Scanning of In Vivo Human Sensory and Communication Systems
(NOT-DC-24-025)
National Institute on Deafness and Other Communication Disorders
- Notice of Special Interest (NOSI): Administrative Supplements to NCATS CTSA Program
KL2/K12 Institutional Career Development Awards as part of the INCLUDE (Investigation
of Co-occurring Conditions across the Lifespan to Understand Down syndrome) Project
(NOT-TR-24-015)
National Center for Advancing Translational Sciences
Funding Opportunities
- New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial
Optional)
(PAR-24-160)
National Institute on Aging
National Cancer Institute
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
- New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial
Optional)
(PAR-24-161)
National Institute on Aging
National Cancer Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV
Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed)
(PAR-24-162)
National Institute of Diabetes and Digestive and Kidney Diseases
- Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial
Optional)
(PAR-24-164)
National Institute of Mental Health
- AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
(PAR-24-165)
National Institute of Mental Health
- Nathan Shock Centers of Excellence in Basic Biology of Aging (P30 Clinical Trial Not
Allowed)
(RFA-AG-25-012)
National Institute on Aging
- Nathan Shock Centers Coordinating Center (U24 Clinical Trial Not Allowed)
(RFA-AG-25-013)
National Institute on Aging
- Tailoring HIV Curative Strategies to the Participant (UM1 Clinical Trial Not Allowed)
(RFA-AI-24-011)
National Institute of Allergy and Infectious Diseases
- Limited Competition: Research Resource for Natural Product Nuclear Magnetic Resonance
Data (R24 Clinical Trial Not Allowed)
(RFA-AT-24-007)
National Center for Complementary and Integrative Health
Office of Dietary Supplements
- Optimizing Health of Children and Adolescents with Perinatal HIV Exposure (U19 Clinical
Trial Optional)
(RFA-HD-25-004)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Deafness and Other Communication Disorders
National Institute of Mental Health
- BRAIN Initiative: Data Archives for the BRAIN Initiative (R24 Clinical Trial Optional)
(RFA-MH-25-110)
National Institute of Mental Health
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Neurological Disorders and Stroke
Office of Behavioral and Social Sciences Research
- Lethal Means Safety Suicide Prevention Research in Healthcare and Community Settings
(R34 Clinical Trial Required)
(RFA-MH-25-120)
National Institute of Mental Health
- BRAIN Initiative: Next-Generation Devices for Recording and Modulation in the Human
Central Nervous System (UG3/UH3 Clinical Trial Optional)
(RFA-NS-24-016)
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Mental Health
- BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording
and Modulation in the Human Central Nervous System (UH3 Clinical Trial Optional)
(RFA-NS-24-017)
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Mental Health
- BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation
Technologies in the Human CNS (R18 - Clinical Trial Not Allowed)
(RFA-NS-24-031)
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Mental Health
- Mechanisms of Cognitive Fluctuations in ADRD Populations (R01 - Clinical Trial Optional)
(RFA-NS-25-014)
National Institute of Neurological Disorders and Stroke
National Institute on Aging
- NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)
(RFA-RM-24-002)
Office of Strategic Coordination (Common Fund)
- NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional)
(RFA-RM-24-003)
Office of Strategic Coordination (Common Fund)
- NIH Directors Transformative Research Awards (R01 Clinical Trial Optional)
(RFA-RM-24-004)
Office of Strategic Coordination (Common Fund)
- NIH Directors Early Independence Awards (DP5 Clinical Trial Optional)
(RFA-RM-24-005)
Office of Strategic Coordination (Common Fund)
- Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not
Allowed)
(RFA-RM-24-007)
Office of Strategic Coordination (Common Fund)